Log In
BCIQ
Print this Print this
 

MDY-1001

  Manage Alerts
Collapse Summary General Information
Company Midway Pharmaceuticals Inc.
DescriptionOrally available, non-systemically absorbed polymer that inhibits the pathogenic behavior of bacteria in the GI tract without the use of antibiotics
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationIrritable bowel syndrome
Indication DetailsTreat irritable bowel syndrome (IBS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today